Back
Santander Bank Polska SA Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
13
BKZHF
Santander Bank Polska SA
Last Price:
45.48
Seasonality Move:
0%
Sell
44
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Sell
13
Santander Bank Polska SA (BKZHF)
is a Sell
Is Santander Bank Polska SA a Buy, Sell or Hold?
- The current Santander Bank Polska SA [BKZHF] share price is $45.48. The Score for BKZHF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- BKZHF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BKZHF Stock Price Chart
What is Santander Bank Polska SA's stock price today?
-
The Santander Bank Polska SA share price today is $45.48
The current trend is relatively stagnant and BKZHF is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
BKZHF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.48 - 45.48) | Buy |
Bollinger Bands (100): | (45.48 - 45.48) | Buy |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 44.04 | Sell |
Chaikin Money Flow: | 27576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.13 - 42.69) | Sell |
Bollinger Bands (100): | (27.3 - 41.42) | Buy |
BKZHF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.48 | Sell |
20-day SMA: | 45.48 | Sell |
50-day SMA: | 45.48 | Sell |
200-day SMA: | 45.48 | Sell |
8-day EMA: | 45.48 | Sell |
20-day EMA: | 45.48 | Sell |
50-day EMA: | 45.48 | Sell |
200-day EMA: | 45.49 | Sell |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.48 | Sell |
20-day SMA: | 41.45 | Sell |
50-day SMA: | 40.72 | Sell |
200-day SMA: | 31.06 | Buy |
8-day EMA: | 40.12 | Sell |
20-day EMA: | 40.8 | Sell |
50-day EMA: | 39.41 | Sell |
200-day EMA: | 32.87 | Buy |
Santander Bank Polska SA Earnings Growth & BKZHF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Santander Bank Polska SA Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |